天使综合征药物研究进展汇总
Notice: Undefined variable: class_attr in /home/wwwroot/angelman/wp-content/themes/ripro/inc/theme-functions.php on line 274
clinicaltrials
- The Global Angelman Syndrome Registry
- CHAMPION: A Study to Evaluate the Efficacy and Safety of Obudanersen (ION582) in Children and Adults With Angelman Syndrome (AS)
- Phase III Clinical Study of Rugonersen in Angelman Syndrome.
- Phase 3 Efficacy and Safety Study of GTX-102 in Pediatric Subjects With Angelman Syndrome (AS)
- Long-term Extension of GTX-102 in Angelman Syndrome
- A Natural History Study of Angelman Syndrome
- IDMet (RaDiCo Cohort) (RaDiCo-IDMet)
- Web Intervention for Parents of Youth With Genetic Syndromes (WINGS)
- A Phase 1/2 Study of the Safety and Efficacy of MVX-220 in Angelman Syndrome
- HALOS: A Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of Multiple Ascending Doses of ION582 in Participants With Angelman Syndrome
- A Safety and Efficacy Study of GTX-102 in Subjects With Deletion- or Nondeletion-type Angelman Syndrome (AS)
- Expanded Access/Compassionate Use of Rugonersen in Patients With Angelman Syndrome
- A Study in Adults and Adolescents With Angelman Syndrome (STARS)
- An Open-Label Study to Evaluate the Long-Term Safety, Tolerability, and Efficacy of OV101 in Individuals With Angelman Syndrome
- Italian Angelman Syndrome Registry Protocol
asnews
